Answers are grounded in this paper and cite their sources.
Combination therapy shows rapid improvement of immune-related hepatitis in solid tumor patients, suggesting a new treatment strategy.
Despite the small sample size, early combination therapy with MMF and systemic steroids rapidly improved ir-hepatitis, consequently reducing the cumulative systemic steroid dosage.
No takes yet. Share an insight, caveat, or question.
Igawa et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: